Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protothecosis.

Sara M Kantrow1, Alan S Boyd

  • 1Division of Dermatology, Department of Pathology, Vanderbilt University, Dermatology 3900, The Vanderbilt Clinic, Nashville, TN 37232, USA.

Dermatologic Clinics
|May 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell immunopathology of recurrent acute generalized exanthematous pustulosis associated with vancomycin.

The journal of allergy and clinical immunology. Global·2025
Same author

Extradigital Symplastic Glomus Tumor and Review of the Literature.

The American Journal of dermatopathology·2024
Same author

An erythematous nodule on the nose.

International journal of dermatology·2024
Same author

Acral keratosis with eosinophilic dermal deposits: A rare subtype of colloid milium.

Journal of cutaneous pathology·2022
Same author

Cutaneous dermatomycosis with concurrent <i>Paecilomyces lilacinus</i> and <i>Candida guilliermondii</i> in a patient with longstanding diabetes.

JAAD case reports·2021
Same author

Case Report: Infantile Urticaria as a Herald of Neonatal Onset Multisystem Inflammatory Disease With a Novel Mutation in NLRP3.

Frontiers in immunology·2021
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Amphotericin B is the top treatment for Prototheca infections, especially severe cases. For localized infections, consider azole antifungals like itraconazole or surgical removal.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Prototheca infections are rare but can be serious.
  • Treatment strategies vary based on disease severity and patient factors.

Purpose of the Study:

  • To review the efficacy of different treatment modalities for Prototheca infections.
  • To provide guidance on first-line and alternative therapies.

Main Methods:

  • Literature review of existing studies on Prototheca treatment.
  • Analysis of treatment outcomes based on drug class and disease presentation.

Main Results:

  • Intravenous amphotericin B is the most effective agent for disseminated Prototheca infections.
  • Itraconazole (200 mg/day for 2 months) shows promise for localized disease.

Related Experiment Videos

  • Surgical excision is a primary option for olecranon bursal Prototheca infections.

    • Conclusions:

    • Amphotericin B should be the first-line treatment for severe or disseminated Prototheca infections.
    • Azole antifungals and surgery are appropriate for localized disease.
    • Tailoring treatment to infection severity and patient status is crucial.